Caniplas® Fresh Frozen Canine Plasma is a blood product intended for clinical transfusion in dogs. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Caniplas may aid in the treatment of a wide variety of canine illnesses, protecting dogs against the depletion of blood clotting factors and the onset of potentially fatal infection.
Caniplas is rich in gamma globulins and is collected from hyperimmunised donor dogs that reside at the Plasvacc production facility in Queensland, Australia.

Caniplas can be used to supplement the immune response system of dogs and has been seen to be a highly effective treatment for a wide variety of canine illnesses and infections, including Pancreatitis, Coagulopathies, Parvovirus infection and Failure of Passive Transfer in puppies.

Plasma transfusions can also be used in cases of major tissue damage, such as injuries sustained during motor vehicle accidents or during the performance of major surgery (for example, amputation). In these instances, Caniplas transfusions can protect the dog against the depletion of blood clotting factors and the onset of potentially fatal infection. When used to complement conventional veterinary treatments, Caniplas can shorten the course of treatments, reduce hospitalization periods and lessen the quantity of drugs required to restore your dog’s health.
Caniplas_Fresh Frozen Canine Plasma_Factsheet
Caniplas_Indications for Use in Canine Medicine_Factsheet
Caniplas_Directions for Use_Factsheet
Caniplas_Indications_Factsheet